Bronchioloalveolar carcinoma;Le carcinome bronchiolo-alvéolaire

Revue des Maladies Respiratoires

Volumn 22, Issue 6 C2, 2005, Pages

  Wislez, M ^b   Gounant, V ^b   Cadranel, J ^a  

^a HÔPITAL TENON   (France)

^b NONE

Author keywords

Bronchioloalveolar carcinoma

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; ERLOTINIB; GEFITINIB; PACLITAXEL;

CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER SURGERY; CLINICAL FEATURE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; HISTOPATHOLOGY; HUMAN; LUNG ALVEOLUS CELL CARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SURGERY; PROGNOSIS; REVIEW;

ADENOCARCINOMA; BRONCHIAL NEOPLASMS; HUMANS; LUNG NEOPLASMS; PULMONARY ALVEOLI;

EID: 33244471086     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: 10.1019/200530084     Document Type: Review

References (32)

1. nd ed. Berlin, Springer, 1999.
2. Travis WD, Garg K, Franklin WA, Wistuba II, Sabloff B, Noguchi M, Kakinuma R, Zakowski M, Ginsberg M, Padera R, Jacobson F, Johnson BE, Hirsch F, Brambilla E, Flieder DB, Geisinger KR, Thunnisen F, Kerr K, Yankelevitz D, Franks TJ, Calvin JR, Henderson DW, Nicholson AG, Hasleton PS, Roggli V, Tsao MS, Cappuzzo F, Vazquez M : Evolving concepts in the pathology and computed tomography imaging of lung adenocarcinoma and bronchioloalveolar carcinoma. J Clin Oncol 2005 ; 23 : 3279-87.
3. Manning JT Jr., Spjut HJ, Tschen JA : Bronchioloalveolar carcinoma: The significance of two histopathologic types. Cancer 1984 ; 54 : 525-34.
4. Mori M, Rao SK, Popper HH, Cagle PT, Fraire AE : Atypical adenomatous hyperplasia of the lung: a probable forerunner in the development of adenocarcinoma of the lung. Mod Pathol 2001 ; 14 : 72-84.
5. Barsky SH, Cameron R, Osann KE, Tomita D, Holmes EC : Rising incidence of bronchioloalveolar lung carcinoma and its unique clinicopathologic features. Cancer 1994 ; 73 : 1163-70.
6. Grover FL, Piantadosi S : Recurrence and survival following resection of bronchioloalveolar carcinoma of the lung-The Lung Cancer Study Group experience. Ann Surg 1989 ; 209 : 779-90.
7. Breathnach OS, Kwiatkowski DJ, Finkelstein DM, Godleski J, Sugarbaker DJ, Johnson BE, Mentzer S : Bronchioloalveolar carcinoma of the lung: recurrences and survival in patients with stage I disease. J Thorac Cardiovasc Surg 2001 ; 121 : 42-7.
8. Fujimoto N, Segawa Y, Takigawa N, Hotta K, Kishino D, Shimono M, Nakata M, Saeki H, Mandai K, Eguch K : Clinical investigation of bronchioloalveolar carcinoma: a retrospective analysis of 53 patients in a single institution. Anticancer Res 1999 ; 19 : 1369-73.
9. Breathnach OS, Ishibe N, Williams J, Linnoila RI, Caporaso N, Johnson BE : Clinical features of patients with stage IIIB and IV bronchioloalveolar carcinoma of the lung. Cancer 1999 ; 86 : 1165-73.
10. Feldman ER, Eagan RT, Schaid DJ : Metastatic bronchioloalveolar carcinoma and metastatic adenocarcinoma of the lung: comparison of clinical manifestations, chemotherapeutic responses, and prognosis. Mayo Clin Proc 1992 ; 67 : 27-32.
11. Schraufnagel D, Peloquin A, Pare JA, Wang NS : Differentiating bronchioloalveolar carcinoma from adenocarcinoma. Am Rev Respir Dis 1982 ; 125 : 74-9.
12. Trigaux JP, Gevenois PA, Goncette L, Gouat F, Schumaker A, Weynants P : Bronchioloalveolar carcinoma: computed tomography findings. Eur Respir J 1996 ; 9 : 11-6.
13. Okubo K, Mark EJ, Flieder D, Wain JC, Wright CD, Moncure AC, Grillo HC, Mathisen DJ : Bronchoalveolar carcinoma: clinical, radiologic, and pathologic factors and survival. J Thorac Cardiovasc Surg 1999 ; 118 : 702-9.
14. Harpole DH, Bigelow C, Young WG Jr., Wolfe WG, Sabiston DC Jr. Alveolar cell carcinoma of the lung: a retrospective analysis of 205 patients. Ann Thorac Surg 1988 ; 46 : 502-7.
15. Regnard JF, Santelmo N, Romdhani N, Gharbi N, Bourcereau J, Dulmet E, Levasseur P : Bronchioloalveolar lung carcinoma: results of surgical treatment and prognostic factors. Chest 1998 ; 114 : 45-50.
16. Ludington LG, Verska JJ, Howard T, Kypridakis G, Brewer LA 3rd : Bronchiolar carcinoma (alveolar cell), another great imitator; a review of 41 cases. Chest 1972 ; 61 : 622-8.
17. Greco RJ, Steiner RM, Goldman S, Coder H, Patchefsky A, Cohn HE : Bronchoalveolar cell carcinoma of the lung. Ann Thorac Surg 1986 ; 41 : 652-6.
18. Heikkila L : Results of surgical treatment in bronchioloalveolar carcinoma. Ann Chir Gynaecol 1986 ; 75 : 183-91.
19. Dumont P, Gasser B, Rouge C, Massard G, Wihlm JM : Bronchoalveolar carcinoma: histopathologic study of evolution in a series of 105 surgically treated patients. Chest 1998 ; 113 : 391-5.
20. Daly RC, Trastek VF, Pairolero PC, Murtaugh PA, Huang MS, Allen MS, Colby TV : Bronchoalveolar carcinoma: factors affecting survival. Ann Thorac Surg 1991 ; 51 : 368-76; discussion 376-7.
21. Wislez M, Massiani MA, Milleron B, Souidi A, Carette MF, Antoine M, Cadranel J : Clinical characteristics of pneumonic-type adenocarcinoma of the lung. Chest 2003 ; 123 : 1868-77.
22. Bellocq A, Antoine M, Flahault A, Philippe C, Crestani B, Bernaudin JF, Mayaud C, Milleron B, Baud L, Cadranel J : Neutrophil alveolitis in bronchioloalveolar carcinoma: induction by tumor-derived interleukin-8 and relation to clinical outcome. Am J Pathol 1998 ; 152 : 83-92.
23. Lynch TJ, Bell DW, Sordella R, Gurubhagavatula S, Okimoto RA, Brannigan BW, Harris PL, Haserlat SM, Supko JG, Haluska FG, Louis DN, Christiani DC, Settleman J, Haber DA : Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 2004 ; 350 : 2129-39.
24. Paez JG, Janne PA, Lee JC, Tracy S, Greulich H, Gabriel S, Herman P, Kaye FJ, Lindeman N, Boggon TJ, Naoki K, Sasaki H, Fujii Y, Eck MJ, Sellers WR, Johnson BE, Meyerson M : EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 2004 ; 304 : 1497-500.
25. Shigematsu H, Lin L, Takahashi T, Nomura M, Suzuki M, Wistuba II, Fong KM, Lee H, Toyooka S, Shimizu N, Fujisawa T, Feng Z, Roth JA, Herz J, Minna JD, Gazdar AF : Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers. J Natl Cancer Inst 2005 ; 97 : 339-46.
26. Wislez M, Rabbe N, Marchal J, Milleron B, Crestani B, Mayaud C, Antoine M, Soler P, Cadranel J : Hepatocyte growth factor production by neutrophils infiltrating bronchioloalveolar subtype pulmonary adenocarcinoma: role in tumor progression and death. Cancer Res 2003 ; 63 : 1405-12.
27. Noguchi M, Morikawa A, Kawasaki M, Matsuno Y, Yamada T, Hirohashi S, Kondo H, Shimosato Y : Small adenocarcinoma of the lung. Histologic characteristics and prognosis. Cancer 1995 ; 75 : 2844-52.
28. Liu YY, Chen YM, Huang MH, Perng RP : Prognosis and recurrent patterns in bronchioloalveolar carcinoma. Chest 2000 ; 118 : 940-7.
29. Gaeta M, Caruso R, Barone M, Volta S, Casablanca G, La Spada F : Ground-glass attenuation in nodular bronchioloalveolar carcinoma: CT patterns and prognostic value. J Comput Assist Tomogr 1998 ; 22 : 215-9.
30. Hsu CP, Chen CY, Hsu NY : Bronchioloalveolar carcinoma. J Thorac Cardiovasc Surg 1995 ; 110 : 374-81.
31. West HL, Crowley JJ, Vance RB, Franklin WA, Livingston RB, Dakhil SR, Giguere JK, Rivkin SE, Kraut M, Chansky K, Gandara DR; Southwest Oncology Group : Advanced bronchioloalveolar carcinoma: a phase II trial of paclitaxel by 96-hour infusion (SWOG 9714): a Southwest Oncology Group study. Ann Oncol 2005 ; 28 : 1076-80.
32. Miller VA, Hirsch FR, Johnson DH : Systemic therapy of advanced bronchioloalveolar cell carcinoma: challenges and opportunities. J Clin Oncol 2005 ; 23 : 3288-93.